Gerner EW - Search Results

1

Polyamine contents in rectal and buccal mucosae in humans treated with oral difluoromethylornithine.

Boyle JO, Meyskens FL Jr, Garewal HS, Gerner EW. Boyle JO, et al. Among authors: gerner ew. Cancer Epidemiol Biomarkers Prev. 1992 Jan-Feb;1(2):131-5. Cancer Epidemiol Biomarkers Prev. 1992. PMID: 1306095

2

Ornithine decarboxylase and polyamine levels in columnar upper gastrointestinal mucosae in patients with Barrett's esophagus.

Garewal HS, Gerner EW, Sampliner RE, Roe D. Garewal HS, et al. Among authors: gerner ew. Cancer Res. 1988 Jun 1;48(11):3288-91. Cancer Res. 1988. PMID: 3130189

3

Gastrointestinal tissue polyamine contents of patients with Barrett's esophagus treated with alpha-difluoromethylornithine.

Gerner EW, Garewal HS, Emerson SS, Sampliner RE. Gerner EW, et al. Cancer Epidemiol Biomarkers Prev. 1994 Jun;3(4):325-30. Cancer Epidemiol Biomarkers Prev. 1994. PMID: 8061581

4

Ornithine decarboxylase and polyamines in colorectal neoplasia and mucosa.

Hixson LJ, Garewal HS, McGee DL, Sloan D, Fennerty MB, Sampliner RE, Gerner EW. Hixson LJ, et al. Among authors: gerner ew. Cancer Epidemiol Biomarkers Prev. 1993 Jul-Aug;2(4):369-74. Cancer Epidemiol Biomarkers Prev. 1993. PMID: 8348060

5

Development of difluoromethylornithine (DFMO) as a chemoprevention agent.

Meyskens FL Jr, Gerner EW. Meyskens FL Jr, et al. Among authors: gerner ew. Clin Cancer Res. 1999 May;5(5):945-51. Clin Cancer Res. 1999. PMID: 10353725 Review.

6

Ornithine decarboxylase activity in Barrett's esophagus: a potential marker for dysplasia.

Garewal HS, Sampliner R, Gerner E, Steinbronn K, Alberts D, Kendall D. Garewal HS, et al. Gastroenterology. 1988 Mar;94(3):819-21. doi: 10.1016/0016-5085(88)90259-4. Gastroenterology. 1988. PMID: 3338650

7

The effect of difluoromethylornithine on decreasing prostate size and polyamines in men: results of a year-long phase IIb randomized placebo-controlled chemoprevention trial.

Simoneau AR, Gerner EW, Nagle R, Ziogas A, Fujikawa-Brooks S, Yerushalmi H, Ahlering TE, Lieberman R, McLaren CE, Anton-Culver H, Meyskens FL Jr. Simoneau AR, et al. Among authors: gerner ew. Cancer Epidemiol Biomarkers Prev. 2008 Feb;17(2):292-9. doi: 10.1158/1055-9965.EPI-07-0658. Cancer Epidemiol Biomarkers Prev. 2008. PMID: 18268112 Free PMC article. Clinical Trial.

8

Combination chemoprevention for colon cancer targeting polyamine synthesis and inflammation.

Gerner EW, Meyskens FL Jr. Gerner EW, et al. Clin Cancer Res. 2009 Feb 1;15(3):758-61. doi: 10.1158/1078-0432.CCR-08-2235. Clin Cancer Res. 2009. PMID: 19188144 Free PMC article. Review.

9

Polyamines as mediators of APC-dependent intestinal carcinogenesis and cancer chemoprevention.

Rial NS, Meyskens FL, Gerner EW. Rial NS, et al. Among authors: gerner ew. Essays Biochem. 2009 Nov 4;46:111-24. doi: 10.1042/bse0460008. Essays Biochem. 2009. PMID: 20095973 Free PMC article. Review.

10

Levels of rectal mucosal polyamines and prostaglandin E2 predict ability of DFMO and sulindac to prevent colorectal adenoma.

Thompson PA, Wertheim BC, Zell JA, Chen WP, McLaren CE, LaFleur BJ, Meyskens FL, Gerner EW. Thompson PA, et al. Among authors: gerner ew. Gastroenterology. 2010 Sep;139(3):797-805, 805.e1. doi: 10.1053/j.gastro.2010.06.005. Epub 2010 Jun 9. Gastroenterology. 2010. PMID: 20538001 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

210 results

Search Page

Filters